Promising prostate cancer trial for hispanic and black patients pulled before start
Disease control
Terminated
This was a phase 2 trial testing a combination of niraparib and abiraterone plus prednisone for metastatic hormone-sensitive prostate cancer in Hispanic/Latino and Black patients with specific gene mutations. The study aimed to enroll 64 people but was withdrawn before any partic…
Phase: PHASE2 • Sponsor: Qian Qin • Aim: Disease control
Last updated Jun 23, 2026 11:58 UTC